MC
RDHL

Menta Capital’s Redhill Biopharma RDHL Stock Holding History

Menta Capital’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$368K Sell
57
-11
-16% -$84.7K 0.16% 248
2019
Q1 		$569K Sell
68
-26
-28% -$206K 0.25% 150
2018
Q4 		$521K Buy
94
+8
+9% +$61.3K 0.19% 146
2018
Q3 		$757K Buy
+86
New +$701K 0.26% 93

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Menta Capital's RDHL Position: Q2 2019 in Review

Menta Capital reduced its Redhill Biopharma (RDHL) stake by 16% in Q2 2019, selling an estimated $84.7K and leaving 57 shares worth $368K. The position accounts for 0.16% of the portfolio, ranked #248.

Menta Capital first reported a position in RDHL in Q3 2018 and has held it in 4 quarters since. The position peaked at $757K in Q3 2018. 34 funds tracked by Wall St. Rank hold RDHL as of Q2 2019.

  • Menta Capital held 57 shares of Redhill Biopharma worth $368K as of Q2 2019.
  • Menta Capital sold 11 Redhill Biopharma shares in Q2 2019, an estimated $84.7K.
  • Redhill Biopharma made up 0.16% of Menta Capital's portfolio in Q2 2019, its #248 holding.
  • Menta Capital first reported a position in Redhill Biopharma in Q3 2018 and has held it in 4 quarters since.
  • Menta Capital's Redhill Biopharma position peaked at $757K in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.